Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
1 minute read

Annji Pharmaceutical Has Entered Into An Exclusive License Agreement With Avenue Therapeutics For AJ201 For Spinal And Bulbar Muscular Atrophy, Also Known As Kennedy’s Disease; Upfront Payment Of $3M, Milestone Payments Of Upto $250M

By Benzinga Newsdesk
March 10, 7:05 AM
The deal covers the U.S., Canada, European Union, Great Britain, And Israel. Avenue will also issue 831,618 shares as equity upfront and additional shares upon the achievement of a clinical milestone, aggregating

ATXI

Read More
1 minute read

Reported Late Thursday March 9, MediciNova Announces Additional Extension Of BARDA Contract To Develop MN-166 As A Medical Countermeasure Against Chlorine Gas-induced Lung Injury; Contract Was Amended To Extend The Period Of Performance Until May 31, 2…

By Happy Mohamed
March 10, 1:27 AM
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced a modification to its contract with

MNOV

Read More
1 minute read

The Metals Company Announced Earlier It Engaged Bechtel to Support NORI’s Commercial Contract Application for NORI–D Nodule Project

By Charles Gross
March 9, 5:56 PM
The Metals Company (NASDAQ: TMC) (the "Company" or "TMC"), an explorer of the world's largest estimated undeveloped source of critical battery metals today announced that Bechtel Australia Pty Ltd (Bechtel), a global leader in engineering, procurement and construction will collect and compile the techno-economic studies prepare

TMC